ERBB2 and metastatic malignant neoplasm in the lymph nodes: No significant association was shown in correlating menstruation, lymph node metastasis, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2) with the level of CD14+CD16+ monocytes.